A detailed history of Radnor Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Radnor Capital Management, LLC holds 12,311 shares of LLY stock, worth $9.8 Million. This represents 1.62% of its overall portfolio holdings.

Number of Shares
12,311
Holding current value
$9.8 Million
% of portfolio
1.62%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$772.14 - $960.02 $9.51 Million - $11.8 Million
12,311 New
12,311 $10.9 Million
Q1 2024

Apr 11, 2024

SELL
$592.2 - $792.28 $133,245 - $178,263
-225 Reduced 2.09%
10,536 $8.2 Million
Q4 2023

Jan 11, 2024

SELL
$525.19 - $619.13 $525 - $619
-1 Reduced 0.01%
10,761 $6.27 Million
Q3 2023

Oct 12, 2023

BUY
$434.7 - $599.3 $4.68 Million - $6.45 Million
10,762 New
10,762 $5.78 Million
Q1 2023

Apr 06, 2023

BUY
$310.63 - $364.82 $633,374 - $743,867
2,039 Added 43.93%
6,681 $2.29 Million
Q4 2022

Jan 09, 2023

SELL
$321.55 - $374.67 $1,929 - $2,248
-6 Reduced 0.13%
4,642 $1.67 Million
Q3 2022

Oct 12, 2022

SELL
$296.48 - $337.87 $110,290 - $125,687
-372 Reduced 7.41%
4,648 $1.5 Million
Q2 2022

Jul 11, 2022

SELL
$278.73 - $327.27 $80,831 - $94,908
-290 Reduced 5.46%
5,020 $1.63 Million
Q1 2022

Apr 25, 2022

BUY
$234.69 - $291.66 $82,610 - $102,664
352 Added 7.1%
5,310 $1.52 Million
Q4 2021

Jan 20, 2022

BUY
$224.85 - $279.04 $1.11 Million - $1.38 Million
4,958 New
4,958 $1.37 Million
Q3 2021

Oct 26, 2021

SELL
$221.6 - $272.71 $1.2 Million - $1.48 Million
-5,420 Closed
0 $0
Q2 2021

Jul 21, 2021

SELL
$180.55 - $233.54 $88,469 - $114,434
-490 Reduced 8.29%
5,420 $1.24 Million
Q4 2020

Jan 13, 2021

BUY
$130.46 - $172.63 $19,569 - $25,894
150 Added 2.6%
5,910 $998,000
Q3 2020

Nov 02, 2020

SELL
$146.22 - $169.13 $43,866 - $50,739
-300 Reduced 4.95%
5,760 $853,000
Q2 2020

Jul 28, 2020

SELL
$136.42 - $164.18 $27,283 - $32,836
-200 Reduced 3.19%
6,060 $990,000
Q1 2020

Apr 07, 2020

SELL
$119.05 - $147.35 $53,572 - $66,307
-450 Reduced 6.71%
6,260 $868,000
Q2 2019

Jul 18, 2019

SELL
$110.79 - $129.32 $55,395 - $64,660
-500 Reduced 6.93%
6,710 $743,000
Q1 2019

Apr 25, 2019

SELL
$111.31 - $131.02 $211,489 - $248,938
-1,900 Reduced 20.86%
7,210 $936,000
Q4 2018

Jan 16, 2019

SELL
$105.9 - $118.64 $32,829 - $36,778
-310 Reduced 3.29%
9,110 $1.05 Million
Q3 2018

Oct 04, 2018

SELL
$85.86 - $107.31 $34,773 - $43,460
-405 Reduced 4.12%
9,420 $1.01 Million
Q2 2018

Jul 10, 2018

SELL
$75.7 - $86.88 $11,355 - $13,032
-150 Reduced 1.5%
9,825 $838,000
Q4 2017

Feb 02, 2018

SELL
$81.94 - $87.89 $15,568 - $16,699
-190 Reduced 1.87%
9,975 $842,000
Q2 2017

Aug 09, 2017

BUY
N/A
10,165
10,165 $837,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Radnor Capital Management, LLC Portfolio

Follow Radnor Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Radnor Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Radnor Capital Management, LLC with notifications on news.